Omega-3 Fatty Acids (DHA/EPA) 研究图表

Figure 14 Chart

Adverse event reporting and safety data demonstrate the tolerability of combined LCPUFA and carotenoid supplementation in older adults.

Effects of Long-Chain Polyunsaturated Fatty Acids in Combination with Lutein and Zeaxanthin …

Figure 15 Chart

Correlation analysis between blood fatty acid levels and episodic memory improvements explores dose-response relationships in the supplementation trial.

Effects of Long-Chain Polyunsaturated Fatty Acids in Combination with Lutein and Zeaxanthin …

Figure 16 Chart

Additional cognitive domain scores including attention and language fluency are compared between groups as secondary outcome measures.

Effects of Long-Chain Polyunsaturated Fatty Acids in Combination with Lutein and Zeaxanthin …

Figure 5. Combined analysis of the changes (∆-adjusted) in the scores of episodic memory function tests for subgroups with cognitive decline in Trials 1 and 2. (A) composite memory; (B), verbal memory; (C), visual memory. LCPUFAs, long-chain polyunsaturat

Figure 17 Chart

Combined analysis of episodic memory score changes in subgroups with low versus adequate baseline omega-3 status indicates differential treatment responses to LCPUFA supplementation with lutein and zeaxanthin.

Effects of Long-Chain Polyunsaturated Fatty Acids in Combination with Lutein and Zeaxanthin …

Figure 2 Forest Plot

Forest plot of randomized controlled trials evaluates the pooled effect of omega-3, DHA, and EPA supplementation on cognitive function scores in Alzheimer's disease patients.

The effects of omega-3, DHA, EPA, Souvenaid® in Alzheimer's disease: A systematic …

Figure 3 Forest Plot

Subgroup analysis by intervention type separates the effects of pure omega-3 supplements from the multinutrient Souvenaid formulation on Alzheimer's disease outcomes.

The effects of omega-3, DHA, EPA, Souvenaid® in Alzheimer's disease: A systematic …

Figure 4 Forest Plot

Forest plot assessing the impact of omega-3 supplementation on functional daily living activities in Alzheimer's disease patients across included trials.

The effects of omega-3, DHA, EPA, Souvenaid® in Alzheimer's disease: A systematic …

Figure 5 Chart

Risk of bias assessment for included studies is visualized using the Cochrane tool, indicating overall moderate quality of evidence across the meta-analysis.

The effects of omega-3, DHA, EPA, Souvenaid® in Alzheimer's disease: A systematic …

Figure 6 Chart

Funnel plot analysis evaluates publication bias across the studies included in the systematic review of omega-3 fatty acids for Alzheimer's disease.

The effects of omega-3, DHA, EPA, Souvenaid® in Alzheimer's disease: A systematic …

Fig 1. The possible mechanisms of action of compound nutrients. Ach: acetylcholine; cAMP: Cycilic adenosine monophospate; APP: amyloid precursor protein-presenilin; Aβ: anti-β-amyloid; GSH-PX: glutathione peroxidase; SOD: superoxide dismutase; TChE: total

Figure 4 Diagram

A schematic diagram illustrates the proposed mechanisms by which the compound nutrient mixture may protect against Alzheimer's pathology, including acetylcholine and cAMP signaling.

Protective Effects of Dietary Supplementation with a Combination of Nutrients in a …

There was no significant difference in the daily food intake across groups (LG, 3.39 ± 0.18 g; HG, 3.34 ± 0.22 g; MG, 3.63 ± 0.26 g; NG, 3.51 ± 0.23 g), and over time, the body weights of all the mice (regardless of group affiliation) were similar up to 9

Figure 5 Chart

Daily food intake across groups confirms consistent consumption, with no significant differences between the low, high, and model groups during the study.

Protective Effects of Dietary Supplementation with a Combination of Nutrients in a …

Figure 6 Chart

Biochemical markers of oxidative stress and antioxidant capacity in brain tissue are compared across treatment groups, showing dose-dependent protective effects.

Protective Effects of Dietary Supplementation with a Combination of Nutrients in a …

Fig 4. Results from Morris water maze tests. (A) The average incubation period from the first to fifth day for the four groups. After 3 months and 7 months of intervention, the mice in HG and NG spent much less time searching for new (reversal) hidden pla

Figure 7 Chart

Morris water maze test results reveal that nutrient-supplemented APP-PSN mice demonstrate shorter escape latency and improved spatial memory compared to untreated transgenic controls.

Protective Effects of Dietary Supplementation with a Combination of Nutrients in a …

Fig 5. Immunofluorescence staining with rabbit anti-Aβ1–42 and HE dyeing of the temporal cortex and hippocampus of APP/PSN mice. (1) LG and HG: APP/PSN (Fig 5A) mice with 7 months of intervention; MG: APP/PSN (Fig 5B) mice without intervention and their w

Figure 8 Micrograph

Immunofluorescence staining of amyloid-beta plaques in the temporal cortex and hippocampus shows reduced plaque burden in nutrient-treated APP-PSN transgenic mice.

Protective Effects of Dietary Supplementation with a Combination of Nutrients in a …

Figure 6 Chart

Experimental results examining a Novel Combination of High, with data points illustrating key findings related to omega-3 fatty acids have been shown to exert several beneficial effects in the prevention of cardiovascular and cereb.